INTRODUCTION
Chagas' disease is a major public health problem endemic in Central and South American countries, with 18-20 million infected people, 25 % of the human population at risk of infection, ca. 200000 new cases annually, and 21000 deaths per year. 1) Its causative agent is Trypanosoma cruzi (T. cruzi), a parasitic protozoan transmitted to mammalian hosts by blood-sucking triatomine bugs. T. cruzi undergoes three main developmental stages during its life cycle: the replicative epimastigote form in insect vectors and the trypomastigote and amastigote forms in mammalian hosts. Nondividing and infective trypomastigotes circulate in the blood with their free flagellum before invading host cells, preferably muscle cells, where they lose their flagellum to differentiate into replicative amastigotes. 2) Infections by T. cruzi result in a lifethreatening, acute, and/or chronic disease with severe cardiac complications. This situation is worsened by the lack of effective vaccines, undesirable side effects of anti-chagasic drugs in use such as ni- * To whom correspondence should be addressed: National Institute of Health Sciences (NIHS), 1-18-1, Kamiyoga, Setagayaku, Tokyo 158-8501, Japan. Tel.: +81-3-3700-8764; Fax: +81-3-3707-6950; E-mail: nuchiyama@nihs.go.jp furtimox and benznidazole, and the emergence of parasite resistance to these drugs. Therefore, new chemotherapeutic agents are urgently needed. Advances in our understanding of the basic biochemistry of T. cruzi have allowed the identification of new specific pathways and novel drug targets for chemotherapy, such as sterol biosynthesis, trypanothione reductase, and cystein protease. 1, [3] [4] [5] [6] This has led to some rationally designed and synthesized candidates for the treatment of Chagas' disease. 4) On the other hand, the use of natural products for the treatment of protozoal infections is well known and long documented. 4) A number of recent works reported the trypanocidal activity of a wide variety of extracts of natural medicines or its constituents. 7, 8) In our screening work on many medicinal plants used in Asian countries, especially Vietnam and Uzbekistan for trypanocidal activity, several extracts of the plants or its constituents showed trypanocidal activity against T. cruzi. 9) Extensive reviews of chemotherapy against Chagas' disease have been reported. 4, 7, 8) Thus, I mainly review recent studies on the antichagasic activities of natural products. 
TRYPANOCIDAL COMPOUNDS ISOLATED FROM MEDICINAL PLANTS

Phenylpropanoids
An acetone extract of rhizomes of Alpinia galanga (Zingiberaceae) showed strong trypanocidal activity against epimastigotes of T. cruzi with a minimum lethal concentration (MLC) of 1.56 µg/ml. Fractionation of the extract resulted in the isolation of seven known phenylpropanoids, 1 -acetoxychavicol acetate (1), 1 -acetoxyeugenol acetate (2), p-coumaryl diacetate (3), coniferyl diacetate (4), p-coumaryl acetate (5), 1 -hydroxychavicol acetate (6) , and p-acetoxycinnamaldehyde (7), as shown in Fig. 1 . The MLCs of these compounds against epimastigotes of T. cruzi were 6.7 µM (1), 12 µM (2), 27 µM (3), 24 µM (4), 8.1 µM (5), > 260 µM (6) , and 132 µM (7), respectively (Table 1) . 9) 
Flavonoids
An acetone extract of roots of Sophora flavescens (Leguminosae) exhibited trypanocidal activity against epimastigotes of T. cruzi with an MLC of 6.25 µg/ml. (16) , and alopecurone G (17) were isolated as trypanocidal compounds (Fig. 1) . The MLCs of these compounds against epimastigotes of T. cruzi were 3.7 µM (8), 14 µM (9), 7.1 µM (10), 7.2 µM (11), 6.9 µM (12), 71 µM (13), 5.5 µM (14), 18 µM (15), 4.4 µM (16), and 3.6 µM (17), respectively (Table 1 ). 10) Although some flavonoids have been reported to have trypanocidal activity, [14] [15] [16] this was the first report of trypanocidal activity for prenylated flavonoids. Among the isolated flavanones, those with a lavandulyl group (8, 9, 11, 12, 14, 17) showed stronger activity than those with a prenyl group (13, 15) , suggesting that prenyl groups may play important roles in the activity. In fact, naringenin, a flavanone with no prenyl group, showed only very weak trypanocidal activity (MLC = 370 µM). 10) Furthermore, two flavonoids were isolated from the ethyl acetate (EtOAc) extract of Dracocephalum kotschyi (Labiatae) and identified as isokaempferide (18) and apigenin (19) , as shown in Fig. 1 . These compounds have trypanocidal activity against epimastigotes of T. cruzi with MLCs of 30 µM and (13) 10) leachianone A (14) 10) (20) 12) IC 50 14.8 (3.9 µg/ml) (trypo) 3 -hydroxydaidzein (21) 12) IC 50 17.4 (4.7 µg/ml) (trypo) Gentian violet
70 µM, respectively ( 
Terpenoids Monoterpenes Four monoterpene hydroperoxides, (−)-(2S,4S)-and (−)-(2R,4S)-p-mentha-1(7),8-dien-2-hydroperoxide (23 and 24) and (−)-(1R,4S)-and (−)-(1S,4S
)-pmentha-2,8-dien-1-hydroperoxide (25 and 26), were isolated from aerial parts of Chenopodium ambrosioides (Chenopodiaceae) along with monoterpene endoperoxide ascaridole (22) as trypanocidal compounds (Fig. 2) . The MLCs of these compounds against epimastigotes of T. cruzi were 23 µM (22), 1.2 µM (23), 1.6 µM (24), 3.1 µM (25), and 0.8 µM (26), respectively ( Table 2) . 17) Meanwhile, the alcohols, corresponding to the hydroperoxides 23-26, did not show trypanocidal activity even at 400 µM, indicating that the hydroperoxy group is essential for the activity of this type of compound. On the other hand, in the HeLa cell infection assay, 26 almost completely inhibited the infection of trypomastigotes to HeLa cells at 1 µg/ml (6.5 µM), and 24 and 25 inhibited the infection by 63 % and 88 % at 1 µg/ml (6.0 and 6.5 µM), respectively. However, they did not inhibit the proliferation of amastigotes in infected cells. 17) Another monoterpene hydroperoxide (1R,4S)-1-hydroperoxy-p-menth-2-en-8-ol acetate (27) , isolated from Laurus nobilis (L. nobilis) L. (Lauraceae), also showed trypanocidal activity against epimastigotes of T. cruzi with MLC of 1.4 µM (Fig. 2, Table 2 ). In a HeLa cell infection assay at 1 µg/ml (4.4 µM), 27 inhibited the infection of trypomastigotes to HeLa cells and the proliferation of amastigotes in HeLa cells by 98 % and 83 %, respectively. hydroperoxide (30) , were isolated as the trypanocidal constituents of Pogostemon cablin (Labiatae), as shown in Fig. 2 . The MLCs of 28-30 against epimastigotes of T. cruzi were 0.84 µM (28), 1.7 µM (29), and 1.7 µM (30) ( Table 2) . However, the activity levels of the corresponding alcohols of 28-30 were very weak (> 200 µM). Thus the trypanocidal activity of the sesquiterpene hydroperoxides is ascribable to the hydroperoxy function. 19) On the other hand, several sesquiterpene lactones having an α,β-unsaturated γ-lactone moiety have shown trypanocidal activity. The structures and trypanocidal activity of these compounds are exhibited in Fig. 2 3 µM) , whereas 34 weakly inhibited proliferation and did not inhibit infection at 1 µg/ml (3.4 µM). 18) Brengio et al. reported that the trypanocidal effect of dehydrocouledine (35) was irreversible but could be blocked by the presence of reducing substances such as thiol compound. 23) This suggested that the trypanocidal activity of this group of compounds depends on covalent bond formation of the α,β-unsaturated γ-lactone moiety with nucleophiles that are essential for the life of the parasite. Trypanosomes are known to be sensitive to oxidative stresses. As a defense against these stresses, they use trypanothione (1,8-bis-glutathionyl spermidine), whose counterpart in mammalian cells is glutathione. α,β-Unsaturated γ-lactones will react with -SH groups of trypanothione and of enzymes involved in the trypanothione cycle, 24) thus inactivating the defense system and exposing the parasite to oxidative damage. 18) Helenalin (36) and mexicanin I (37), which also have an α,β-unsaturated γ-lactone moiety, exhibited IC 50 values of 0.7 and 1.9 µM, respectively, against trypomastigotes of T. cruzi. 22) However, Jimenez-Ortiz et al. reported that 36 and 37 are deleterious for epimastigotes of T. cruzi and that their mechanism of action is different from that of the related lactone (35) . 25) 
Diterpenes
Previously, the trypanocidal activity of several types of diterpenes has been reported. (Fig. 3, Table 3 ). 26, 27) Cassane diterpenes, 18-hydroxycassan-13,15-diene (42), 6β,18-dihydroxycassan-13,15-diene (43), 6β-hydroxy-18-acetoxycassan-13,15-diene (44), 18-acetoxy-13,15-diene-19-cassanoic acid (45), and 6β,13β-dihydroxy-18-acetoxycassan-14(17),15-diene (46), were also reported to show trypanocidal activity against trypomastigotes and amastigotes of T. cruzi with IC 50 values in the range of 11.5-104 µM and 16.6-35.8 µM, respectively (Fig. 3, Table 3 ). 28) Two new norditerpene aldehydes, (2E)-rel- (52), and previtexilactone (53), which were isolated from Vitex trifolia (Verbenaceae), exhibited trypanocidal activity with MLCs against epimastigotes of T. cruzi (Fig. 3) . The MLCs of 47-53 against epimastigotes of T. 28) IC 50 48.6/17.4 (trypo/ama) 6β,18-dihydroxycassan-13,15-diene (43) 28) IC 50 56.0/16.6 (trypo/ama) 6β-hydroxy-18-acetoxycassan-13,15-diene (44) 28) IC 50 11.5/25.9 (trypo/ama) 18-acetoxy-13,15-diene-19-cassanoic acid (45) 28) IC 50 104.0/ND b)
(trypo/ama) 6β,13β-dihydroxy-18-acetoxycassan-14(17),15-diene (46) 28) IC 50 16. Table 3) . 29) On the other hand, two novel icetexanes, komaroviquinone (54) and cyclocoulterone (55), four new 20-norabietane diterpenes, dracocequinones A (56), B (57), dracocephalone A (58) and komarovinone A (59), and a new diterpene with a spiro-octahydroindene skelton (komarovispirone, 60) were isolated from Dracocephalum komarovi (Labiatae, Fig. 4) . 13, 31, 32) The trypanocidal activities of the isolated compounds are summarized in 33) In fact, we found that 54 was reduced by T. cruzi old yellow enzyme (TcOYE) to its semiquinone radical, which subsequently generates superoxide anion radicals (Fig. 5) . The komaroviquinone (54) reductase activity in trypanosoma lysates was completely immunoabsorbed by anti-TcOYE antibody. These results indicate that TcOYE is the main source of 54 reductase activity in T. cruzi, and this in turn implies that the trypanocidal activity of 54 is specifically due to its reduction by the parasite enzyme TcOYE. 34) Therefore, the trypanocidal activity of 54, 56, and 57 may be due to the generation of a reactive oxygen species. Furthermore, a novel icetexane diterpene, 5-epiicetexane (61, Fig. 4 ) obtained from Salvia gilliessi, was effective against epimastigotes of T. cruzi with IC 50 value of 6.5 ± 0.75 µM (Table 3) . 30) Thus, the trypanocidal activity of diterpenes (42-52, 55-57, 60, and 61) were in a similar range except for kaurane diterpenes (38-41). However, 54 showed more potent activity than the other diterpenes. Compound 54 at its high concentration (3 µM) did not inhibit the intracellular growth of amastigotes within HeLa cells. However, 54 inhibited the survival of trypomastigotes more potently than that of epimastigotes with an IC 50 value of 9 nM and inhibited infection with trypomastigotes to HeLa cells with the same IC 50 value (9 nM). Furthermore, 54 showed selective toxicity between the parasite and HeLa cells, calculated to be about 2200-fold. 34) These results clearly indicate that 54 is a good candidate for developing new antichagasic drugs.
OTHER COMPOUNDS
In our current study, fungal metabolites, isolated from Aspergillaceae, were identified as a new type of trypanocidal compounds. These compounds showed potent trypanocidal activity against amastigotes, epimastigotes, and trypomastigotes of T. cruzi in the µM range (data not shown). 35) Thus, further study is necessary to clarify the mechanisms of action of these compounds.
CONCLUSION
Despite many research efforts, currently there are no drugs in clinical trial for the treatment of Chagas' disease. However, the wide range of therapeutic targets under investigation should hasten the discovery of novel trypanocidal compounds that can be made into effective, widely available drugs. Although various natural products have been identified as trypanocidal compounds, there is little information that enables the identification of the mechanisms of action with most of these products. Further investigation is required, not only to identify trypanocidal compounds from natural medicines but also to reveal those compounds' mechanisms of action.
